- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center in Silver Spring, MD. As quoted in the press release: The pilot program is expected to start on October 4, 2017. The Company expects to announce the name of its weight-loss program upon anticipated successful …
BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center in Silver Spring, MD.
As quoted in the press release:
The pilot program is expected to start on October 4, 2017. The Company expects to announce the name of its weight-loss program upon anticipated successful completion of the pilot program in Q4 2017.
According to the CDC, more than one-third (36.5%) of U.S. adults have obesity. According to a 2012 article in the Journal of Health Economics, estimates of current healthcare costs of obesity range from $147 billion to nearly $210 billion per year. Some of the risks associated with this disease include heart disease and stroke, high blood pressure, metabolic syndrome, breathing problems and other health issues.
Dr. Benjamin Gonzalez, Medical Director of Atlantis Medical Wellness & Weight Loss Center, is renowned for his expertise in clinical nutrition with a focus on exercise nutrition and weight management. Dr. Gonzalez will be speaking at the A4M/MMI Weight Symposium on October 6-7, 2017 in Boston, MA. Information about the event can be found at https://www.a4m.com/weight-symposium-boston-2017.html. At this event, Dr. Gonzalez plans to introduce the potential benefits of the naltrexone implant for weight loss.
Dr. Gonzalez, stated, “We know how difficult losing weight can be. Our goal is to address the problems of the overweight and obese and enable individuals to regain control of their lives and health by giving them the necessary life skills to lose weight and achieve a healthy lifestyle. I’m very excited to introduce the implant as a potential groundbreaking medication therapy for weight loss providing sustained release naltrexone over many months.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.